AtriCure - Stock Price History | ATRC

Historical daily share price chart and data for AtriCure since 2020 adjusted for splits. The latest closing stock price for AtriCure as of February 21, 2020 is 39.41.
  • The all-time high AtriCure stock closing price was 43.84 on February 14, 2020.
  • The AtriCure 52-week high stock price is 44.51, which is 12.9% above the current share price.
  • The AtriCure 52-week low stock price is 22.57, which is 42.7% below the current share price.
  • The average AtriCure stock price for the last 52 weeks is 30.08.
AtriCure Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 29.1289 30.2500 33.3400 23.8100 32.5100 6.24%
2018 26.1470 18.4700 35.5800 15.0500 30.6000 67.76%
2017 20.3076 19.2000 24.8800 14.9400 18.2400 -6.80%
2016 16.5649 21.1600 21.4700 13.5400 19.5700 -12.79%
2015 21.8535 19.7800 27.9300 17.4000 22.4400 12.42%
2014 17.5247 18.0300 22.1800 13.6400 19.9600 6.85%
2013 10.3316 7.1400 18.9300 7.1400 18.6800 170.72%
2012 8.5684 11.7400 11.9600 5.9100 6.9000 -37.84%
2011 11.4511 10.2500 14.5000 8.5400 11.1000 8.08%
2010 6.7755 5.6500 10.2700 4.5600 10.2700 70.03%
2009 3.2447 2.2000 6.0500 1.0700 6.0400 172.07%
2008 9.7793 13.2400 14.0500 2.0000 2.2200 -83.07%
2007 10.6159 9.1500 13.5900 8.4400 13.1100 46.64%
2006 8.1361 10.7900 11.8000 5.4400 8.9400 -16.06%
2005 13.1674 14.0800 14.9500 10.6500 10.6500 0.00%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $1.610B $0.231B
AtriCure, Inc. is a medical device company focused on developing, manufacturing and selling innovative surgical devices to create precise lesions, or scars, in soft tissues. Medical journals have described the adoption by leading cardiothoracic surgeons of the AtriCure, Inc. bipolar ablation system as a standard treatment alternative during open-heart surgical procedures to safely, rapidly and reliably create lesions in cardiac, or heart, tissue to block the abnormal electrical impulses that cause atrial fibrillation, a quivering of the upper chambers of the heart.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $156.438B 27.30
Medtronic (MDT) Ireland $152.615B 20.51
Stryker (SYK) United States $84.081B 27.18
Boston Scientific (BSX) United States $59.238B 26.73
Baxter (BAX) United States $47.512B 28.81
EssilorLuxottica Societe Anonyme (ESLOY) France $33.568B 0.00
Zimmer Biomet Holdings (ZBH) United States $32.578B 20.13
Lonza Group Ag (LZAGY) Switzerland $31.806B 0.00
Coloplast (CLPBY) Denmark $30.478B 47.03
Terumo (TRUMY) Japan $26.454B 33.01
ResMed (RMD) United States $25.453B 44.22
Smith & Nephew SNATS (SNN) United Kingdom $22.585B 0.00
Sunny Optical Technology (SNPTF) China $18.226B 0.00
Insulet (PODD) United States $13.381B 636.59
Bio-Rad Laboratories (BIO) United States $12.245B 57.21
Perrigo (PRGO) Ireland $8.113B 15.13
William Demant Holdings (WILYY) Denmark $7.896B 0.00
Canopy Growth (CGC) Canada $7.794B 0.00
GN STORE NORD (GNNDY) Denmark $7.537B 38.94
Hill-Rom Holdings (HRC) United States $7.179B 20.65
DiaSorin S.p.A (DSRLF) Italy $7.161B 0.00
Haemonetics (HAE) United States $6.009B 36.99
Shandong Weigao Medical Polymer (SHWGF) China $5.020B 0.00
ICU Medical (ICUI) United States $4.452B 29.02
Envista Holdings (NVST) United States $4.387B 0.00
NuVasive (NUVA) United States $4.110B 31.84
GW Pharmaceuticals (GWPH) United Kingdom $3.971B 0.00
Neogen (NEOG) United States $3.791B 63.10
Agios Pharmaceuticals (AGIO) United States $3.678B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.661B 0.00
Quidel (QDEL) United States $3.398B 29.83
National Vision Holdings (EYE) United States $2.856B 64.46
Aurora Cannabis (ACB) Canada $1.964B 0.00
TG Therapeutics (TGTX) United States $1.575B 0.00
Cardiovascular Systems (CSII) United States $1.501B 0.00
InMode (INMD) Israel $1.278B 0.00
NanoString Technologies (NSTG) United States $1.190B 0.00
Aphria (APHA) $1.137B 0.00
Phibro Animal Health (PAHC) United States $1.085B 21.45
VAREX IMAGING (VREX) United States $0.991B 20.59
PetIQ (PETQ) United States $0.988B 24.10
Cerus (CERS) United States $0.860B 0.00
Quanterix (QTRX) United States $0.796B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.715B 27.38
Omeros (OMER) United States $0.674B 0.00
Lantheus Holdings (LNTH) United States $0.650B 16.25
LeMaitre Vascular (LMAT) United States $0.615B 34.93
MacroGenics (MGNX) United States $0.563B 0.00
Surmodics (SRDX) United States $0.509B 58.52
Owens & Minor (OMI) United States $0.449B 16.63
Organigram Holdings (OGI) Canada $0.438B 0.00
HEXO (HEXO) $0.409B 0.00
OraSure Technologies (OSUR) United States $0.378B 47.15
Zynex (ZYXI) United States $0.360B 40.67
Utah Medical Products (UTMD) United States $0.358B 25.42
Meridian Bioscience (VIVO) United States $0.339B 13.64
BioLife Solutions (BLFS) United States $0.332B 135.08
Female Health (VERU) United States $0.299B 0.00
Repro-Med Systems (KRMD) United States $0.287B 0.00
Bovie Medical (APYX) United States $0.259B 0.00
InfuSystems Holdings (INFU) United States $0.233B 1175.00
Viemed Healthcare (VMD) United States $0.217B 22.92
Rockwell Medical (RMTI) United States $0.205B 0.00
Cytosorbents (CTSO) United States $0.202B 0.00
Vapotherm (VAPO) United States $0.198B 0.00
United Health Products (UEEC) United States $0.187B 0.00
Liberty Health Sciences (LHSIF) Canada $0.179B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.174B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.137B 0.00
Fonar (FONR) United States $0.131B 9.54
Chimerix (CMRX) United States $0.106B 0.00
Surface Oncology (SURF) United States $0.101B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.088B 0.00
MRI Interventions (CLPT) United States $0.084B 0.00
United-Guardian (UG) United States $0.080B 20.29
MTech Acquisition (KERN) United States $0.077B 0.00
Nephros (NEPH) United States $0.071B 0.00
Chembio Diagnostics (CEMI) United States $0.068B 0.00
FSD PHARMA INC (HUGE) Canada $0.045B 0.00
ImmuCell (ICCC) United States $0.037B 0.00
NF Energy Saving (BIMI) China $0.031B 0.00
Trinity Biotech (TRIB) Ireland $0.023B 0.00
GUARDION HEALTH (GHSI) United States $0.023B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.014B 0.00
Senestech (SNES) United States $0.007B 0.00
Capricor Therapeutics (CAPR) United States $0.006B 0.00
Myomo (MYO) United States $0.004B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00
Akers Biosciences Inc (AKER) United States $0.002B 0.00